SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,710.17 |
| Enterprise Value ($M) | 2,886.53 |
| Book Value ($M) | 194.04 |
| Book Value / Share | 0.65 |
| Price / Book | 13.97 |
| NCAV ($M) | -86.25 |
| NCAV / Share | -0.29 |
| Price / NCAV | -31.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.09 |
| Return on Assets (ROA) | -0.07 |
| Return on Equity (ROE) | -0.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.60 |
| Current Ratio | 3.39 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 504.74 |
| Assets | 785.03 |
| Liabilities | 590.99 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 528.29 |
| Operating Income | 34.06 |
| Net Income | -56.11 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -33.89 |
| Cash from Investing | -0.56 |
| Cash from Financing | 5.12 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Redmile Group, LLC | |||
| 13G/A | Perceptive Advisors Llc | |||
| 13G/A | Wellington Management Group Llp | |||
| 13G/A | BlackRock, Inc. | |||
| 13G | William Blair Investment Management, Llc | 5.30 | ||
| 13G/A | Avoro Capital Advisors LLC | 7.80 | -15.42 | |
| 13G/A | Jpmorgan Chase & Co | 4.30 | -26.73 | |
| 13G/A | Vanguard Group Inc | 9.72 | 7.36 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 567,918 | 2,120,552 | 26.78 | |
| 517,780 | 2,706,702 | 19.13 | |
| 525,578 | 4,011,069 | 13.10 | |
| 368,558 | 2,203,195 | 16.73 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FATE – Fate Therapeutics, Inc. | FBLG – FibroBiologics, Inc. |
| FHTX – Foghorn Therapeutics Inc. | FULC – Fulcrum Therapeutics, Inc. |
| GANX – Gain Therapeutics, Inc. |